Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
8/2018 due to acquisition
GeneSort
GeneSort Overview
GeneSort is a molecular diagnostics company focused on integrating molecular genomics with personalized therapeutic approaches. The company's mission is to use patients' genetic DNA profile to assist physicians in selecting safe, effective, tailored treatments.
GeneSort is focused on providing diagnostic services in the areas of cancer and hereditary diseases.
The company has been acquired in July 2018 by Hong Kong investment fund AID Partners for $23 million.
GeneSort Climate Tech relevance
undefined
Companies you might be interested in
Driven by Finder AI
Latest News
No Data, yet.
Sorry, no content found under this section.
Jul 16, 2018
pulsenews.co.kr
ACT to acquire Israel cancer molecular diagnosis company GeneSort for $17.8 mn - Pulse by Maeil Business News Korea